SCLX

Scilex Holding Company SCLX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SCLX IRD ABOS CTOR INO IXHL SEER AGEN LUCD VTGN
6M 241.49 % 142.27 % 98.13 % -23.81 % 2.50 % 109.21 % -14.49 % -19.18 % -9.69 % 92.31 %
YTD 7.79 % 86.51 % 14.59 % -5.88 % 12.64 % -78.64 % -24.03 % 22.93 % 46.73 % 28.01 %
1Y -6.80 % 135.00 % 7.61 % 1.82 % -4.65 % -77.29 % -28.63 % 34.22 % 44.40 % 71.37 %
3Y -86.65 % 82.17 % -63.19 % -90.20 % -90.86 % -86.73 % -71.63 % -92.94 % -30.24 % 18.06 %
5Y -95.23 % 82.17 % -89.45 % -90.20 % -98.36 % -97.10 % -97.33 % -94.82 % -90.09 % -81.11 %
10Y -95.23 % 82.17 % -89.45 % -90.20 % -97.22 % -97.10 % -96.87 % -95.11 % -90.09 % -97.30 %
From the beginning -95.23 % 82.17 % -89.45 % -90.20 % -99.71 % -97.10 % -96.87 % -99.95 % -90.09 % -99.71 %

Dividend

Inovio Pharmaceuticals, Inc.